Kunadian B, Dunning J, Das R, Roberts A P, Morley R, Turley A J, Twomey D, Hall J A, Wright R A, Sutton A G C, Muir D F, de Belder M A
Department of Cardiology, The James Cook University Hospital, Middlesbrough, UK.
Heart. 2008 Aug;94(8):1012-8. doi: 10.1136/hrt.2007.129197. Epub 2007 Nov 21.
Workable risk models for patients undergoing percutaneous coronary intervention (PCI) are needed urgently.
To validate two proposed risk adjustment models (Mayo Clinic Risk Score (MC), USA and North West Quality Improvement Programme (NWQIP), UK models) for in-hospital PCI complications on an independent dataset of relatively high risk patients undergoing PCI.
Tertiary centre in northern England.
Between September 2002 and August 2006, 5034 consecutive PCI procedures (validation set) were performed on a patient group characterised by a high incidence of acute myocardial infarction (MI; 16.1%) and cardiogenic shock (1.7%). Two external models-the NWQIP model and the MC model-were externally validated.
Major adverse cardiovascular and cerebrovascular events: in-hospital mortality, Q-wave MI, emergency coronary artery bypass grafting and cerebrovascular accidents.
An overall in-hospital complication rate of 2% was observed. Multivariate regression analysis identified risk factors for in-hospital complications that were similar to the risk factors identified by the two external models. When fitted to the dataset, both external models had an area under the receiver operating characteristic curve >or=0.85 (c index (95% CI), NWQIP 0.86 (0.82 to 0.9); MC 0.87(0.84 to 0.9)), indicating overall excellent model discrimination and calibration (Hosmer-Lemeshow test, p>0.05). The NWQIP model was accurate in predicting in-hospital complications in different patient subgroups.
Both models were externally validated. Both predictive models yield comparable results that provide excellent model discrimination and calibration when applied to patient groups in a different geographic population other than that in which the original model was developed.
迫切需要适用于接受经皮冠状动脉介入治疗(PCI)患者的可行风险模型。
在接受PCI的相对高危患者的独立数据集中,验证两种提出的风险调整模型(美国梅奥诊所风险评分(MC)和英国西北质量改进计划(NWQIP)模型)用于院内PCI并发症的情况。
英格兰北部的三级中心。
在2002年9月至2006年8月期间,对一组以急性心肌梗死(MI;16.1%)和心源性休克(1.7%)高发病率为特征的患者进行了5034例连续PCI手术(验证集)。对两种外部模型——NWQIP模型和MC模型——进行了外部验证。
主要不良心血管和脑血管事件:院内死亡率、Q波心肌梗死、急诊冠状动脉搭桥术和脑血管意外。
观察到总体院内并发症发生率为2%。多变量回归分析确定的院内并发症危险因素与两种外部模型确定的危险因素相似。当应用于该数据集时,两种外部模型的受试者工作特征曲线下面积均≥0.85(c指数(95%CI),NWQIP为0.86(0.82至0.9);MC为0.87(0.84至0.9)),表明总体模型区分度和校准良好(Hosmer-Lemeshow检验,p>0.05)。NWQIP模型在预测不同患者亚组的院内并发症方面准确。
两种模型均经过外部验证。当应用于不同于原始模型开发人群的不同地理人群中的患者组时,这两种预测模型产生了可比的结果,提供了出色的模型区分度和校准。